Advances in Diagnosis and Management of Multisystem Wilson’s Disease
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 62
Special Issue Editors
Interests: Wilson’s disease; neurodegeneration with brain iron accumulation; stroke; multiple sclerosis; clinical trials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Wilson’s disease (WD) is an autosomal recessive, multi-system disorder of copper metabolism characterized by pathological copper accumulation in various tissues (primarily the liver and brain), leading to organ damage and clinical symptoms—predominantly hepatic and neuropsychiatric. The clinical spectrum of WD is broad, including variations in age of onset, predominant phenotypes, and clinical manifestations. As such, the management and treatment of WD require the involvement of multiple medical specialists (e.g., hepatologists, neurologists, psychiatrists, ophthalmologists, speech therapists, dietitians, etc.).
WD can be effectively treated with anti-copper agents (chelators or drugs that reduce copper absorption from the digestive tract). In select cases, liver transplantation is a treatment option, particularly for individuals with significant hepatic injury. Early diagnosis and initiation of anti-copper therapy are critical for achieving favorable outcomes in WD. However, challenges remain, such as choosing the appropriate drug, managing adverse drug reactions, and establishing a differential diagnosis.
Advances in WD diagnosis are being made, particularly through improvements in genetics, neuroradiology, and serum copper metabolism biomarkers. Treatment options are also evolving, with new developments in gene therapy, anti-copper drugs, and symptomatic treatment. Additionally, monitoring of WD therapy is being refined, with the introduction of novel serum and neuroradiological biomarkers. New aspects of clinical WD symptoms, such as cognition, sleep disturbances, and dysfunctions of smell and taste, are being extensively investigated.
Recently, several copper metabolism disorders that mimic WD have been described, some of which were initially misdiagnosed as WD. It is important to increase awareness of these conditions.
The aim of this Special Issue is to provide a platform for the latest research on the diagnosis and treatment of WD, emphasizing the importance of multidisciplinary involvement. We invite submissions of various types of papers, including research articles, up-to-date reviews, case reports, and commentaries. We also encourage the formulation of hypotheses based on current knowledge that may inspire future research.
We look forward to receiving your contributions.
Dr. Tomasz Litwin
Dr. Agnieszka Antos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Wilson’s disease
- brain magnetic resonance imaging
- biomarkers
- copper metabolism
- Wilson’s disease mimicking disorders
- zinc
- chelators
- liver transplantation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
